Abstract:Background : Triple-negative breast cancer (TNBC) is a highly aggressive tumor subtype associated with poor prognosis. The onset of metastasis in organs such as the lung,bone and brain is a major cause of mortality in TNBC patients. Thus, identification of novel targets for the treatment of triple-negative breastcancer is urgent for improved outcomes in patients with this disease. Methods and Results :Here we conducted quantitative proteomic analyses in breast cancer cell lines, which include a normal, primary tumor and a metastatic tumor that were isolated from a single patient. Stable isotope labeling of amino acid in cell culture followed by LC-MS/MS analysis was performed and deregulated proteins were identified using statistical analysis. We identified for the first time that Rab1B, a member of RAS oncogene family, was down-regulated in high metastatic human breast cancer cells. In a panel of breast tumor tissues, Immunohistochemical analysis demonstrated an inverse correlation between metastatic propensity and the expression of Rab1B. Compared with primary tumors, Rab1B expression was notably decreased in lymph node metastases. Low Rab1B expression also correlated with poorer survival in triple-negative breast cancer patients. Through in vitro assays, we confirmed that silencing of Rab1B expression by RNAi in MDA-MB-231 and MDA-MB-468 breast cancer cells, can potentiate the proclivity to metastasize in Transwell assay and enhance lung colonization by tail vain injection in mice. In a reverse-complimentary approach, we determined that elevated Rab1B expression in highly metastatic breast cancer cell lines (MDA-MB-231HM and MDA-MB-231Bo) can suppress the ability of invasion and metastasis in vitro and in vivo . Mechanistically, we establish that the metastatic behavior strongly correlates with increased phosphorylated Smad3 levels and overexpression of TGF-β type I receptor (TβRI). Conversely, restoration of Rab1B can inhibit the activation of this pathway in MDA-MB-231HM and MDA-MB-231Bo cells. Conclusion :By utilizing a series of mammary tumor cell lines, animal models, and clinically sourced tissues, we demonstrate that Rab1B acts as a metastasis suppressor in triple-negative breast cancer through regulating TGF-β/Smad signaling pathway. Citation Format: HongLin Jiang, Hefen Sun, Wei Jin. Loss of Rab1B promotes triple-negative breast cancer metastasis by activating TGF-β/Smad signaling [abstract]. In: Proceedings of the Thirty-Seventh Annual CTRC-AACR San Antonio Breast Cancer Symposium: 2014 Dec 9-13; San Antonio, TX. Philadelphia (PA): AACR; Cancer Res 2015;75(9 Suppl):Abstract nr P1-07-18.

Rab27A is Involved in Malignant Phenotypes in Human Breast Cancer Cells by Regulating the Expression of Related Genes

Enhanced Expression of Rab27A Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II

Data from Enhanced Expression of <i>rab27a</i> Gene by Breast Cancer Cells Promoting Invasiveness and the Metastasis Potential by Secretion of Insulin-Like Growth Factor-II

Overexpression of the Secretory Small GTPase Rab27B in Human Breast Cancer Correlates Closely with Lymph Node Metastasis and Predicts Poor Prognosis

Effects of Rab27A and Rab27B on Invasion, Proliferation, Apoptosis, and Chemoresistance in Human Pancreatic Cancer Cells.

Rab22a is a Novel Prognostic Marker for Cell Progression in Breast Cancer

Lipophagy-related Gene RAB7A is Involved in Immune Regulation and Malignant Progression in Hepatocellular Carcinoma.

Decreased Expression of Rab27A and Rab27B Correlates with Metastasis and Poor Prognosis in Colorectal Cancer.

Effects of Silencing Rab27a Gene on Biological Characteristics and Chemosensitivity of Non-Small Cell Lung Cancer

Rab26 suppresses migration and invasion of breast cancer cells through mediating autophagic degradation of phosphorylated Src

Inhibition of RAB1A Suppresses Epithelial-Mesenchymal Transition and Proliferation of Triple-Negative Breast Cancer Cells.

The Rab2A GTPase Promotes Breast Cancer Stem Cells and Tumorigenesis Via Erk Signaling Activation.

Rab8A promotes breast cancer progression by increasing surface expression of Tropomyosin-related kinase B

Mir-433 Inhibits Breast Cancer Cell Growth Via the MAPK Signaling Pathway by Targeting Rap1a

Evaluation of the Novel Gene Rabl3 in the Regulation of Proliferation and Motility in Human Cancer Cells.

Mir‑448 Targets Rab2B and is Pivotal in the Suppression of Pancreatic Cancer

The prognostic and immune significance of Rab11A in pan‐cancer and its function and mechanism underlying estrogen receptor targeting in breast cancer

Abstract P1-07-18: Loss of Rab1B Promotes Triple-Negative Breast Cancer Metastasis by Activating TGF-β/Smad Signaling

Rab14 Suppression Mediated by MiR-320a Inhibits Cell Proliferation, Migration and Invasion in Breast Cancer.

RCP is a Human Breast Cancer-Promoting Gene with Ras-activating Function.

MiR-27b directly targets Rab3D to inhibit the malignant phenotype in colorectal cancer